Prevest Denpro Ltd.

BSE: 543363 SECTOR: Medical Equipment/Supplies/Accessories  31k   285   9

427.35
-22.25 (-4.95%)
BSE: Today, 05:10 PM

Price Summary

Today's High

₹ 450

Today's Low

₹ 425

52 Week High

₹ 494.5

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

512.95 Cr.

Enterprise Value

471.98 Cr.

No. of Shares

1.2 Cr.

P/E

32.65

P/B

7.05

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  60.65

CASH

42.34 Cr.

DEBT

1.37 Cr.

Promoter Holding

73.6 %

EPS (TTM)

₹  13.09

Sales Growth

32.12%

ROE

29.07 %

ROCE

39.64%

Profit Growth

60.53 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year32.12%
3 Year24.97%
5 YearNA

Profit Growth

1 Year60.53%
3 Year56.92%
5 YearNA

ROE%

1 Year29.07%
3 Year35.44%
5 Year34.01%

ROCE %

1 Year39.64%
3 Year44.08%
5 Year41.73%

Debt/Equity

0.0239

Price to Cash Flow

73.68

Interest Cover Ratio

60.3404805914972

CFO/PAT (5 Yr. Avg.)

0.893853610006667

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 73.6 0
Dec 2022 73.6 0
Sep 2022 73.6 0
Jun 2022 73.6 0
Mar 2022 73.6 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 56.9236892199954% for the Past 3 years.
  • The company has shown a good revenue growth of 24.9691962312692% for the Past 3 years.
  • Company has been maintaining healthy ROE of 35.4405520914881% over the past 3 years.
  • Company has been maintaining healthy ROCE of 44.0764215463499% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 60.3404805914972.
  • The Company has been maintaining an effective average operating margins of 25.4898907922396% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -53.6793345397037 days.
  • Company has a healthy liquidity position with current ratio of 9.7645304686053.
  • The company has a high promoter holding of 73.6%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
Net Sales 9.39 12.3 11.21 12.27 13.77
Total Expenditure 6.43 7.79 7 7.3 8.17
Operating Profit 2.97 4.51 4.21 4.96 5.6
Other Income 0.8 0.68 0.82 0.5 0.33
Interest 0 0 0 0 0
Depreciation 0.15 0.15 0.19 0.18 0.16
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.62 5.05 4.84 5.28 5.78
Tax 1.15 1.37 1.51 1.69 0.67
Profit After Tax 2.46 3.68 3.33 3.59 5.11
Adjusted EPS (Rs) 2.05 3.07 2.78 2.99 4.25

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 16.98 19.28 22.77 28.48 37.62
Total Expenditure 14.02 15.4 17.58 19.45 22.89
Operating Profit 2.96 3.87 5.19 9.02 14.73
Other Income 0.6 0.49 1.79 1.04 2.11
Interest 0.22 0.21 0.26 0.25 0.27
Depreciation 0.42 0.4 0.44 0.47 0.52
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.93 3.76 6.28 9.34 16.05
Tax 0.76 0.76 1.27 2.13 4.48
Net Profit 2.17 2.99 5.01 7.21 11.57
Adjusted EPS (Rs.) 76.16 105.05 175.74 8.16 9.64

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 0.29 0.29 0.29 0.29 12
Total Reserves 7.02 10.01 15.02 22.21 45.1
Borrowings 1.14 1.39 1.59 1.39 1.37
Other N/C liabilities 0.3 0.32 0.36 0.24 0.29
Current liabilities 2.75 3.33 3.82 6.55 5.4
Total Liabilities 11.5 15.34 21.08 30.68 64.16
Assets
Net Block 3.98 4.97 5.2 5.36 6.72
Capital WIP 0 0 0.11 1.71 4.72
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.34 0.38 0.19 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 7.18 9.99 15.58 23.6 52.72
Total Assets 11.5 15.34 21.08 30.68 64.16
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 2.93 3.76 6.28 9.34 16.05
Adjustment 1.34 0.31 0.21 0.15 -0.6
Changes in Assets & Liabilities -1.24 -0.32 -0.52 1.17 -4.06
Tax Paid -0.6 -0.73 -1.24 -1.9 -4.43
Operating Cash Flow 2.42 3.01 4.73 8.76 6.96
Investing Cash Flow -1.09 -1.23 -0.52 -1.93 -3.87
Financing Cash Flow -0.14 0.09 0.03 -0.57 22.82
Net Cash Flow 1.19 1.87 4.24 6.26 25.91

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 73.60 73.60 73.60 73.60 73.60
atul modi 37.52 36.85 36.85 36.85 36.85
namrata modi 36.03 36.03 36.03 36.03 36.03
vimla modi - 0.67 0.67 0.67 0.67
alka beotra 0.03 0.03 0.03 0.03 0.03
niharika modi 0.03 0.03 0.03 0.03 0.03
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 26.40 26.40 26.40 26.40 26.40
maven india fund - 4.29 - - -
next orbit venture... - 4.15 1.21 1.16 1.16
alpha leon enterpr... - 2.12 - - -
mansi share & stoc... - 1.23 - - -
sharad kanayalal s... 1.10 - 1.04 1.06 1.06

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

Prevest Denpro incorporates wholly owned subsidiary22 May 2023, 2:57PM Prevest Denpro informs about disclosure16 May 2023, 12:00PM Prevest Denpro informs about press release8 May 2023, 4:55PM Prevest Denpro informs about investor presentation8 May 2023, 11:26AM Prevest Denpro - Quaterly Results27 Apr 2023, 2:25PM Prevest Denpro - Quaterly Results27 Apr 2023, 2:25PM Prevest Denpro - Quaterly Results27 Apr 2023, 2:25PM Prevest Denpro - Quaterly Results13 Feb 2023, 1:04PM Prevest Denpro - Quaterly Results13 Feb 2023, 1:04PM Prevest Denpro - Quaterly Results13 Feb 2023, 1:04PM Prevest Denpro informs about trading window closure29 Dec 2022, 3:12PM Prevest Denpro informs about disclosures 26 Dec 2022, 12:48PM Prevest Denpro informs about disclosure 26 Dec 2022, 12:27PM Prevest Denpro informs about board meeting3 Nov 2022, 4:10PM Prevest DenPro opens R&D and Testing Center adjoining to Jammu factory3 Nov 2022, 9:18AM Prevest Denpro informs about proceedings of AGM 17 Sep 2022, 12:16PM Prevest Denpro informs about appointment of CS and CO29 Aug 2022, 12:06PM Prevest Denpro informs about press release22 Aug 2022, 3:05PM Prevest Denpro submits investor presentation 11 Aug 2022, 9:42AM Prevest Denpro informs about press release11 Aug 2022, 9:42AM Prevest Denpro signs MoU with Central University Jammu30 May 2022, 11:29AM Prevest DenPro gets USFDA clearance for Dental Cavity Liners 17 May 2022, 10:53AM Prevest Denpro informs about outcome of board meeting8 Nov 2021, 4:50PM Prevest Denpro coming with an IPO to raise upto Rs 27 crore14 Sep 2021, 2:09PM

Prevest Denpro Stock Price Analysis and Quick Research Report. Is Prevest Denpro an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Prevest Denpro and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 6.9623 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Prevest Denpro has a Debt to Equity ratio of 0.0239 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Prevest Denpro , the EPS growth was 18.1598626946181 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Prevest Denpro has OPM of 39.1633929947852 % which is a good sign for profitability.
     
  • ROE: Prevest Denpro have a healthy ROE of 29.0671541007908 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Prevest Denpro

X